Anti-Cancer Drugs Journal Issues Research Articles in January 2021 Edition
December 21, 2020
December 21, 2020
LONDON, England, Dec. 21 -- Anti-Cancer Drugs, a journal that says it reports clinical and experimental results related to anti-cancer drugs and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation, published research articles on the following topics in its January 2021 edition:
Preclinical Reports:
* Vorinostat and fenretinide synergize in preclinical models of T-cell lymphoid ma . . .
Preclinical Reports:
* Vorinostat and fenretinide synergize in preclinical models of T-cell lymphoid ma . . .